About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Ovarian Cancer Clinical Trials in Massachusetts | 439 Studies

Clinical Trials Ovarian CancerMassachusetts

Ovarian Cancer Clinical Trials in Massachusetts

Find 439 clinical trials for ovarian cancer near Massachusetts. Connect with research centers in your area.

All Ovarian Cancer trials nationwide All trials in Massachusetts

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 361-380 of 439 trials

TerminatedClinical Trial for Ovarian Cancer (OvaRex®)This study will compare the time to disease relapse between OvaRex® MAb-B43.13-treated patients and placebo-treated patients.NCT00050375·Huntsville, Alabama and 61 others

Ovarian Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

Active not recruitingPaclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube CancerThis phase III clinical trial studies two different dose schedules of paclitaxel to see how well they work in combination with carboplatin with or without bevacizumab in treating…NCT01167712·Birmingham, Alabama and 563 others

RecruitingTegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid TumorsThis phase I/II trial evaluates the highest safe dose, side effects, and possible benefits of tegavivint in treating patients with solid tumors that has come back (recurrent) or…NCT04851119·Birmingham, Alabama and 20 others

CompletedA Study of MM-121 in Combination With Paclitaxel in Patients With Advanced Gynecologic and Breast CancersThis study was a Phase 1 and pharmacologic open-labeled dose-escalation trial of MM-121 in combination with paclitaxel using a "3+3" design.NCT01209195·Birmingham, Alabama and 4 others

RecruitingA Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian CancerThis is a clinical study that has three parts.NCT07213804·Birmingham, Alabama and 266 others

RecruitingDT2216 + Paclitaxel in Platinum-Resistant Ovarian CancerThe purpose of this research study is determining the highest dose of the study drug DT2216 in combination with paclitaxel that can be safely and tolerably administered in…NCT06964009·Boston, Massachusetts and 2 others

TerminatedVorinostat, Carboplatin and Gemcitabine in Women With Recurrent, Platinum-Sensitive Ovarian CancerThis trial is a Phase Ib/II study of carboplatin/gemcitabine/vorinostat for the treatment of platinum sensitive recurrent ovarian cancer.NCT00910000·Boston, Massachusetts and 1 other

Active not recruitingStudy to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian CancerThis phase 3 study will be conducted in different countries all over the world.NCT06619236·Anchorage, Alaska and 176 others

CompletedStudy Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 To Treat Small-Volume Ovarian, Peritoneal, Fallopian Tube CancerThe purpose of this study is to determine whether CP-547,632, an oral VEGFR-2 tyrosine kinase inhibitor is effective in the treatment of epithelial ovarian cancer, primary…NCT00074867·Los Angeles, California and 8 others

CompletedS0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.NCT00043082·Mobile, Alabama and 90 others

CompletedPatupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal CancerThe objective of this study is to assess the safety and efficacy of patupilone compared to pegylated liposomal doxorubicin.NCT00262990·Anchorage, Alaska and 148 others

TerminatedSlowed Carboplatin Infusion for Ovarian Cancer Patients Receiving Carboplatin Re-TreatmentThis is a research study to determine if administering carboplatin at a slower rate when re-treating recurrent ovarian cancer patients prior to the development of a…NCT02035345·Boston, Massachusetts

CompletedNiraparib Versus Niraparib-bevacizumab Combination in Women With Platinum-sensitive Epithelial Ovarian CancerPart 1 (Phase 1): safety and tolerability of bevacizumab-Niraparib combination Part 2 (Randomized Phase 2): to compare Progression-Free Survival (PFS) PARP inhibitors are active…NCT02354131·Boston, Massachusetts and 1 other

Not yet recruitingA Preregistered Multi-Cohort Evaluation of the FATHOM AI System for Molecular Testing Prioritization to Support Clinical Trial EnrollmentMany clinical trials evaluating cancer treatments require patients to undergo testing for specific molecular markers as part of eligibility screening, typically using…NCT07814872·Boston, Massachusetts

CompletedSexual Therapy and Rehabilitation After Treatment for Ovarian Cancer (START-OC): A Pilot InterventionThis research study is evaluating an educational intervention for women who have experienced changes in sexual function after treatment for ovarian cancer.NCT02287519·Boston, Massachusetts and 1 other

Not yet recruitingEvaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With CancerThe objective of this study is to assess two novel positron emission tomography (PET) radiotracers, \[64Cu\]CM500 and \[68Ga\]CM500, for Positron Emission Tomography-Magnetic…NCT07781852·Boston, Massachusetts and 2 others

RecruitingA Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003)Researchers are looking for other ways to treat high-grade serous and certain other ovarian cancer. High-grade means the cancer cells grow and spread quickly.NCT06843447·New Haven, Connecticut and 32 others

Active not recruitingA Trial of Vigil for Participants With Ovarian CancerThe goal of this clinical trial is to compare participants with ovarian, fallopian tube or primary peritoneal cancer when treated with investigational product (Vigil) compared to…NCT02346747·Mobile, Alabama and 25 others

RecruitingA First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian CancerThis is a first-in-human, open-label, dose-escalation, dose-optimization trial designed to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and antitumor…NCT07226427·Springdale, Arkansas and 14 others

Active not recruitingCarboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube CancerThis randomized phase III trial studies carboplatin, paclitaxel and gemcitabine hydrochloride when given together with or without bevacizumab after surgery to see how well it…NCT00565851·Anchorage, Alaska and 708 others

PreviousPage 19 of 22Next

Other Conditions in Massachusetts

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia